Background Image
Menu

Latest News

Oxford BioTherapeutics named 'Best Tech SME of the Year' at Thames Valley Tech & Innovation Awards 2024

22 July 2024

Oxford BioTherapeutics named 'Best Tech SME of the Year' at Thames Valley Tech & Innovation Awards 2024

Oxford, UK and San Jose, California, 22 July 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies, announces it has been recognized as the ‘Tech SME of the Year’ at the sixth...

Wirral footcare manufacturer Tectores steps into India

20 June 2024

Wirral footcare manufacturer Tectores steps into India

Footcare product manufacturer Tectores has shifted its manufacturing from China to India as part of an expansion drive. Wirral-based Tectores produces PelliTec, a product that helps prevent blisters forming on feet. It was developed by friends Karl Ormond and Lenny Waters who...

Infex Therapeutics strengthens its senior leadership team

20 May 2024

Infex Therapeutics strengthens its senior leadership team

Alderley Park, Cheshire, U.K. Infex Therapeutics, a leading anti-infectives specialist, announces it has appointed a new Director of Clinical Programmes, and promoted existing staff to strengthen its senior management team. Dr Kerry Nield has joined as Director of Clinical...

Biofortuna completes acquisition of biological sample storage experts Cryoniss

9 May 2024

Biofortuna completes acquisition of biological sample storage experts Cryoniss

Biofortuna Limited, the specialist laboratory services and CDMO, has completed the acquisition of Cryoniss Ltd, underlining its commitment to support life-changing research and development across the global biotech and life sciences sector. The acquisition of Cryoniss brings...

CroBio announces completion of $1.55 million seed round

24 April 2024

CroBio announces completion of $1.55 million seed round

CroBio has announced the completion of $1.55 million seed round.   The round was led by The Grantham Foundation for the Protection of the Environment, with participating investors – SOSV and Ponderosa Ventures, and with continued support from Catapult Ventures.  Read the company...

Precision neuroscience company Monument Therapeutics announces £1.5m funding to kickstart schizophrenia clinical development

22 April 2024

Precision neuroscience company Monument Therapeutics announces £1.5m funding to kickstart schizophrenia clinical development

Manchester, UK, and Cambridge UK, 18 April 2024 - Monument Therapeutics, a precision neuroscience company, today announced new funding of £1.5 million from a combination of equity investment and non-dilutive grant as part of the Innovate UK Future Economy Investor Partnership...

Maxwellia revolutionises menstrual health category in pharmacy with the introduction of Evana® and Ultravana®

9 April 2024

Maxwellia revolutionises menstrual health category in pharmacy with the introduction of Evana® and Ultravana®

Alderley Park, Cheshire, UK - April 08, 2024 - Women’s health champion Maxwellia is pleased to announce the availability of Evana® Heavy Period Relief 500mg tablets (tranexamic acid) and Ultravana® Period Pain Relief 250mg tablets (naproxen) to help women manage heavy and...

Sight and Sound announces partnership with Speaksee

20 March 2024

Sight and Sound announces partnership with Speaksee

Sight and Sound has joined forces with Dutch technology company Speaksee to deliver cutting-edge solutions in the UK. Speaksee’s innovative technology allows for real-time transcription of conversations, making it easier for individuals with hearing loss to follow along and...

Oxford BioTherapeutics announces launch of enhanced discovery platform, OGAP®-Verify, at World ADC Conference 2024

7 March 2024

Oxford BioTherapeutics announces launch of enhanced discovery platform, OGAP®-Verify, at World ADC Conference 2024

• OGAP®-Verify allows for significantly enhanced sensitivity and specificity for improved target selection, dramatically accelerating drug target discovery … • OGAP-Verify is now more sensitive than Immunohistochemistry (IHC), measuring membrane proteins as low as 50...

Pill Connect announces its acceptance onto the leading CDMO’s smart packaging supply program

5 March 2024

Pill Connect announces its acceptance onto the leading CDMO’s smart packaging supply program

Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organization) smart packaging supply program. Following an intensive validation process, the device has passed the product qualification...